Non-CME/CE
Neurology
Alzheimer’s diagnostics are entering a new era with the advent of blood tests, offering the potential for earlier and more streamlined detection within primary care. As these innovative tests progress from research settings into day-to-day clinical practice, it is vital for primary care providers to understand their capabilities, limitations, and the practical steps required to deploy them effectively. This session draws on real-world insights to explore both the challenges and opportunities of integrating blood tests, guiding attendees on how to incorporate these tools to enhance early detection, optimize treatment pathways, and ultimately improve patient outcomes.
Global CEO Initiative on Alzheimer’s Disease